|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 |
| (11) | Number of the document | 1809236 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05747562.6 |
| Date of filing the European patent application | 2005-05-11 | |
| (97) | Date of publication of the European application | 2007-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2012-12-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/005078 |
| Date | 2005-05-11 |
| (87) | Number | WO 2005/110359 |
| Date | 2005-11-24 |
| (30) | Number | Date | Country code |
| 102004024451 | 2004-05-14 | DE |
| (72) |
TRUNK, Michael, DE
SCHIEWE, Joerg, DE
|
| (73) |
Boehringer Ingelheim Pharma GmbH & Co. KG,
Binger Strasse 173, 55216 Ingelheim,
DE
Boehringer Ingelheim International GmbH, Binger Strasse 173, 55216 Ingelheim, DE |
| (54) | PULVERFORMULIERUNGEN FÜR DIE INHALATION, DIE ENANTIOMERENREINE BETAAGONISTEN ENTHALTEN |
| INHALATION POWDER FORMULATIONS CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS |